BECTON, DICKINSON AND COMPANY Funds and ETFs Becton, Dickinson and Company
Equities
BDX
US0758871091
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 235 USD | -0.82% |
|
-0.91% | -3.62% |
| May. 10 | Exclusive-Biden to put tariffs on China medical supplies - sources | RE |
| May. 06 | Barclays Adjusts Price Target on Becton, Dickinson to $312 From $305, Keeps Overweight Rating | MT |
ETFs positioned on Becton, Dickinson and Company
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 15.40% | 254 M€ | +10.27% | - | |
| 2.78% | 2 M€ | 0.00% | - | |
| 2.47% | 6 M€ | +16.84% | - | |
| 2.09% | 17 M€ | +7.01% | - | |
| 1.71% | 4,592 M€ | +11.18% | ||
| 0.87% | 9 M€ | -.--% | - | |
| 0.83% | 2 M€ | +9.27% | ||
| 0.81% | 469 M€ | -2.05% | ||
| 0.81% | 3,859 M€ | +18.82% | - | |
| 0.79% | 2 M€ | +20.44% | - | |
| 0.69% | 5 M€ | -72.95% | - | |
| 0.60% | 5 M€ | -.--% | - | |
| 0.43% | 219 M€ | +17.17% | - | |
| 0.43% | 1,448 M€ | -.--% | - | |
| 0.43% | 727 M€ | +8.46% | ||
| 0.38% | 8 M€ | +4.88% | ||
| 0.33% | 25 M€ | +4.02% | - | |
| 0.32% | 9 M€ | +9.41% | ||
| 0.31% | 85 M€ | +11.59% | - | |
| 0.30% | 276 M€ | +11.40% | - | |
| 0.29% | 1,848 M€ | +18.39% | - | |
| 0.29% | 559 M€ | +14.30% | ||
| 0.27% | 8 M€ | +5.15% | - | |
| 0.27% | 744 M€ | +8.55% | ||
| 0.27% | 1,006 M€ | -.--% | - | |
| 0.27% | 414 M€ | +11.73% | - | |
| 0.26% | 26 M€ | +20.69% | - |
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows:
- medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.;
- diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.;
- clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc.
Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Calendar
2024-06-09
- Ex-dividend day
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A
Sell
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
235
USD
Average target price
278.8
USD
Spread / Average Target
+18.65%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -3.62% | 67.92B | |
| -5.51% | 181B | |
| +2.33% | 112B | |
| +1.52% | 50.1B | |
| +8.06% | 44.27B | |
| +9.39% | 40.41B | |
| +23.35% | 31.95B | |
| +0.67% | 25.82B | |
| +17.27% | 25.29B | |
| -1.42% | 24.68B |
- Stock Market
- Equities
- BDX Stock
- Funds and ETFs Becton, Dickinson and Company